Mechanistically, ROS induce NCOA4-dependent ferritinophagy and exacerbate mitochondrial and DNA damage, thereby increasing the sensitivity of human pancreatic cancer cells and tumor-bearing mice to chemotherapeutic agents [293]. The gene discussed is NCOA4; the disease is familial pancreatic carcinoma.